Vytrus launches capital increase in Capital Cell

October 12, 2017

Vytrus Biotech has launched a capital increase, through an investment campaign on the Crowdfunding platform Capital Cell, specialized in biomedicine.

The campaign has already reached 97% and there are still 17 days to go: https://capitalcell.es/campaign/vytrus-biotech/

On the occasion of this campaign Vytrus organizes an informative session next Monday, October 16th, at 12h, where Vytrus Biotech’s project will be explained in more detail: the technology, the business model and the company’s growth plans.

The session will last approximately 20 minutes and Capital Cell will interview the CEO of Vytrus Biotech, Albert Jané, and Xavier Castells, CFO of Inkemia, main investor.

This session can be followed in person at the offices of Capital Cell, Edificio PIER01, Plaça de Pau Vila 1, office 2D2, Barcelona or online via live streaming at: https://www.facebook.com/capitalcellnet/